North America Animal Parasiticides Market Overview
The North America animal parasiticides market was valued at USD 4.54 billion in 2025 and is projected to reach USD 7.50 billion by 2033, growing at a CAGR of 6.67% from 2026 to 2033. The market is supported by sustained demand for preventive and therapeutic parasite control across companion and farm animals, increasing awareness of zoonotic parasite risks, and the continued development of convenient topical, oral, and combination parasiticide products.
North America represents a mature animal-health market with a broad veterinary infrastructure, established pharmaceutical manufacturers, and a large companion-animal population. Fleas, ticks, mites, and intestinal worms remain important parasite-control targets, while climate variability, cross-border animal movement, and travel can contribute to changing parasite exposure patterns. AnimalhealthNorth America identifies parasite control as a cornerstone of veterinary care and notes that parasites can affect both animal and human health.
Key Market Trends & Insights
- U.S dominated the North America animal parasiticides market with the largest revenue share of 77.47% in 2025, supported by supported by its well-established veterinary healthcare infrastructure, high demand for companion-animal healthcare, strong adoption of preventive parasite-control products, and the presence of leading animal health companies and veterinary pharmaceutical manufacturers.
- The ectoparasiticides segment dominated the North America animal parasiticides market with a 49.47% share in 2026, supported by continued demand for flea and tick control products across companion and farm animals.
- Mexico is expected to be the fastest-growing region at a CAGR of 7.09% from 2026 to 2033, fueled by a growing companion animal population, increasing awareness of preventive veterinary care, rising demand for flea and tick control products, and expanding access to veterinary healthcare and animal health products.
- The Organochlorines segment within drug class dominated with a 3.16% share in 2025, while the carbamates segment is projected to register the fastest growth at a CAGR of 6.59% from 2026 to 2033.
- Prescription products dominated the mode of purchase category with a 62.91% share in 2025, reflecting the important role of veterinary diagnosis, treatment recommendations, and prescription-based parasite control.
- Branded products accounted for the largest drug type share at 61.32% in 2025, while generic products are expected to grow faster at a CAGR of 6.48% through 2033.
- Topical products led the route of administration category with a 42.42% share in 2025, whereas oral products are expected to record the fastest CAGR of 6.50% from 2026 to 2033.
Market Size & Forecast
- Market Value (2025): USD 4.54 Billion
- Expected Market Value (2033): USD 7.50 Billion
- Forecast CAGR (2026–2033): 6.67%
- Leading Region in 2025: U.S
- Fastest Growing Region: Mexico
Report Scope and North America Animal Parasiticides Market Segmentation
|
Attributes |
Animal Parasiticides Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework |
North America Animal Parasiticides Market Trends
Trend: Growth in Demand for Novel Biological and Low-Chemical Residue Parasiticide Solutions
The increasing focus on sustainable animal healthcare practices is creating opportunities for the development of novel biological and low-chemical residue parasiticide solutions. Growing awareness regarding environmental impacts, chemical residues, and the need for safer parasite control approaches is encouraging manufacturers to explore alternative solutions that provide effective parasite management while reducing potential risks to animals, humans, and ecosystems. This shift is driving innovation toward advanced formulations with improved safety profiles and sustainable characteristics.
The rising preference for responsible livestock production and eco-conscious companion animal care is further supporting opportunities for companies to develop next-generation parasiticide products. Biological approaches, naturally derived active ingredients, and low-residue formulations can help address evolving regulatory expectations and consumer preferences for safer animal healthcare solutions. As the animal health industry moves toward more sustainable disease prevention strategies, the development of environmentally compatible parasiticides is expected to create new growth opportunities for market participants.
For instances,
-
In October 2025, the U.S. Department of Agriculture (USDA) APHIS highlighted biological control approaches as environmentally sound pest management methods that can reduce dependence on conventional chemical pesticides. The agency emphasized the use of natural biological agents as targeted control solutions within integrated pest management programs.
North America Animal Parasiticides Market Dynamics
Key Market Driver: Increasing Burden of Vector-Borne Parasites Affecting Animal Health
The rising occurrence of vector-borne parasites, including ticks, fleas, mites, and other external parasites, is becoming a significant concern for companion animals and livestock populations. These parasites can negatively impact animal health by causing skin disorders, infections, irritation, reduced immunity, and transmission of various diseases. Increasing exposure of animals to parasite-prone environments, including farms, rural areas, and outdoor habitats, is contributing to greater demand for effective parasite control solutions.
The growing focus on maintaining animal welfare and preventing parasite-related health issues is encouraging the adoption of animal parasiticides across veterinary and agricultural applications. Livestock producers are increasingly prioritizing parasite management to minimize health complications and maintain animal productivity, while pet owners are becoming more proactive toward routine parasite prevention. This shift toward preventive animal healthcare practices is supporting the increased utilization of parasiticide products for controlling vector-borne parasite infestations.
For instance,
-
As reported by the World Organisation for Animal Health (WOAH) in May 2024, vector-borne diseases are emerging as a significant threat to animal health, with vectors such as ticks, mosquitoes, and flies contributing to the spread of diseases among animals. The organization highlighted that changing environmental conditions are influencing vector distribution and increasing the requirement for improved surveillance and control measures for animal health protection.
Key Restraint/Challenge: Development of Parasite Resistance Against Commonly Used Active Ingredients
The increasing development of parasite resistance against commonly used active ingredients is emerging as a significant restraint for the global animal parasiticides market. Repeated and improper use of certain antiparasitic compounds can reduce their effectiveness over time, allowing resistant parasite populations to survive and continue affecting animal health. Resistance among internal and external parasites, including worms, ticks, and other ectoparasites, creates challenges for veterinarians, farmers, and pet owners in maintaining effective parasite control programs.
The reduced response to existing parasiticide treatments is increasing the complexity of parasite management and encouraging the need for alternative control strategies, improved monitoring practices, and development of new active ingredients. Resistance issues can increase treatment costs, require frequent product rotation, and limit the effectiveness of established parasiticide solutions. As resistance continues to impact long-term parasite control efforts, it remains a key challenge that may restrict the broader adoption and effectiveness of conventional animal parasiticides.
For instance,
-
As reported by the U.S. Food and Drug Administration (FDA) in January 2026, concerns regarding antiparasitic resistance in livestock animals continue to require attention, with the agency emphasizing responsible use of approved antiparasitic products and veterinary oversight to maintain treatment effectiveness. The increasing recognition of resistance risks highlights challenges associated with maintaining long-term efficacy of existing parasiticide solutions.
Key Market Opportunity: Expansion of Online Veterinary Services and Digital Animal Healthcare Platforms
The increasing adoption of digital technologies in animal healthcare is creating new opportunities for improving access to veterinary services and parasite management solutions. Online veterinary consultations, digital health platforms, and remote monitoring tools are enabling pet owners and livestock producers to receive timely healthcare guidance, including recommendations for parasite prevention and treatment. These platforms are improving awareness regarding animal health practices and supporting early identification and management of parasite-related conditions.
The growing integration of technology into veterinary care is transforming traditional animal healthcare models by enhancing communication between veterinarians and animal owners. Digital platforms provide opportunities for personalized healthcare recommendations, medication guidance, and continuous monitoring, helping improve compliance with preventive parasite control programs. As digitalization continues to expand across the animal health sector, online veterinary services are expected to support wider adoption of animal parasiticides by improving accessibility and awareness.
For instances,
- As reported by Pet 24-7 Global Ltd in June 2026, the company launched its connected pet healthcare platform in India and Saudi Arabia, integrating digital health records, preventive care reminders, AI-based pet assistance, and veterinary support services. The platform enables pet owners to manage healthcare activities digitally and access veterinary guidance more conveniently.
North America Animal Parasiticides Market Scope
The North America animal parasiticides market is segmented on the basis of product, drug class, mode of purchase, drug type, route of administration, dosage form, disease type, animal type, end user, and distribution channel.
-
By Product
On the basis of product, the market is segmented into ectoparasiticides, endoparasiticides, and endectocides. In 2026, the ectoparasiticides segment is expected to dominate the market with a market share of 49.47%, supported by demand for flea and tick control across companion and farm animals.
The endectocides segment is projected to register the fastest growth at a CAGR of 7.04% from 2026 to 2033, reflecting demand for products providing broader internal and external parasite coverage.
-
By Drug Class
On the basis of drug class, the market is segmented into organochlorines, organophosphates, carbamates, benzimidazoles, imidazothiazoles, and others. In 2026, the others segment is expected to dominate with a market share of 3.15%.
The carbamates segment is expected to register the fastest growth in the North America animal parasiticides market, expanding at a CAGR of 7.50% from 2026 to 2033, driven by increasing demand for effective parasite-control treatments and growing emphasis on preventive animal healthcare.
-
By Mode of Purchase
On the basis of mode of purchase, the market is segmented into prescription and over the counter (OTC). In 2026, prescription products are expected to dominate with a market share of 63.04%, supported by veterinary diagnosis and professional treatment recommendations.
The prescription segment is projected to register the fastest CAGR of 6.89% from 2026 to 2033, mainly due to the increasing demand for prescription-based antiparasitic treatments, greater veterinary healthcare expenditure, and the growing prevalence of parasitic infections in animals.
-
By Drug Type
On the basis of drug type, the market is segmented into branded and generic products. In 2026, branded products are expected to dominate with a market share of 61.21%, supported by established veterinary brands and product recognition.
The generic segment is expected to witness the fastest CAGR of 6.97% from 2026 to 2033, supported by growing demand for cost-effective treatment options, increasing preference for affordable alternatives to branded products, and the wider availability of generic antiparasitic drugs.
-
By Route of Administration
On the basis of route of administration, the market is segmented into topical, oral, injectables, and others. In 2026, topical products are expected to dominate with a market share of 42.35%, supported by their established use in ectoparasite control and convenient application.
The oral segment is expected to witness the fastest CAGR of 7.07% from 2026 to 2033, supported by the convenience of oral administration, ease of dosing, improved treatment compliance, and increasing adoption of systemic parasite-control products.
-
By Dosage Form
On the basis of dosage form, the market is segmented into solution, tablets, sprays, and others. In 2026, solution is expected to dominate with a market share of 44.03%, supported by the widespread use of topical and liquid parasite-control formulations.
The tablets segment is projected to record the fastest CAGR of 6.88% from 2026 to 2033, supported by convenient dosing, ease of administration, improved treatment compliance, and growing demand for oral parasite-control products.
-
By Disease Type
On the basis of disease type, the market is segmented into fleas, ticks, round worms, hookworms, ear mites, and others. In 2026, fleas are expected to dominate with a market share of 27.92%
The ticks segment is expected to witness the fastest CAGR of 7.09% from 2026 to 2033, supported by the growing importance of tick-borne disease prevention, rising awareness of tick-related health risks, and changing parasite exposure pattern.
-
By Animal Type
On the basis of animal type, the market is segmented into companion animal and farm animals. In 2026, companion animals are expected to dominate with a market share of 75.85%, supported by high demand for routine flea, tick, and worm prevention in pets.
The farm animals segment is expected to witness the fastest CAGR of 7.09% from 2026 to 2033, supported by the rising prevalence of parasitic infections, increasing livestock populations, growing emphasis on animal health and productivity, and greater adoption of preventive parasite-control treatments.
-
By End User
On the basis of end user, the market is segmented into veterinary clinics, animal farms, home care, veterinary hospitals, pet shops, and others. In 2026, veterinary clinics are expected to dominate with a market share of 33.30%, reflecting their role in diagnosis, prescription, and parasite-control recommendations.
The home care segment is expected to witness the fastest CAGR of 7.04% from 2026 to 2033, supported by increasing preference for convenient at-home preventive care, greater awareness of routine parasite prevention, and the growing availability of easy-to-administer animal health products.
-
By Distribution Channel
On the basis of distribution channel, the market is segmented into retail sales, direct tender, and other. In 2026, retail sales are expected to dominate with a market share of 67.36%, supported by broad access to companion-animal parasite-control products through retail and pet-care channels.
The direct tender segment is expected to witness the fastest CAGR of 6.99% from 2026 to 2033, supported by increasing institutional and farm-level procurement, rising demand for bulk purchasing, and the growing adoption of organized procurement channels for animal health products.
Germany Animal Parasiticides Market Insight
U.S dominated the North America animal parasiticides market with the largest revenue share of 77.47% in 2025, supported by supported by its well-established veterinary healthcare infrastructure, high demand for companion-animal healthcare, strong adoption of preventive parasite-control products, and the presence of leading animal health companies and veterinary pharmaceutical manufacturers.
U.S. Animal Parasiticides Market Insight
The U.S. animal parasiticides market is driven by high companion-animal ownership, increasing expenditure on preventive veterinary healthcare, strong adoption of routine parasite-control programs, and rising demand for effective treatment against fleas, ticks, mites, gastrointestinal worms, and other internal and external parasites. Market growth is further supported by advanced veterinary infrastructure, availability of prescription and over-the-counter parasiticides, growing livestock health-management practices, and widespread access to animal health products through veterinary clinics, pharmacies, agricultural suppliers, and online platforms.
Canada Animal Parasiticides Market Insight
The Canada animal parasiticides market is supported by increasing companion-animal ownership, rising awareness regarding preventive veterinary care, and the growing importance of parasite management in livestock and farm animals. Market growth is further encouraged by the need for effective control of fleas, ticks, mites, and gastrointestinal parasites, along with established veterinary healthcare services, regulated access to animal medicines, and distribution through veterinary clinics, agricultural channels, and online platforms..
Mexico Animal Parasiticides Market Insight
The Mexico animal parasiticides market is driven by growing pet ownership, increasing awareness of animal health and preventive care, and rising demand for parasite-control solutions across companion animals and livestock. Market growth is further supported by expanding veterinary services, increasing adoption of flea, tick, mite, and gastrointestinal parasite prevention practices, and improved availability of animal healthcare products through veterinary clinics, agricultural suppliers, and retail distribution channels.
North America Animal Parasiticides Market Share
The animal parasiticides industry is primarily led by well-established companies, including:
- Zoetis Inc. (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Bimeda, Inc. (Ireland)
- Biogénesis Bagó (Argentina)
- Ceva Santé Animale (France)
- Dechra Pharmaceuticals (U.K.)
- Elanco Animal Health Incorporated (U.S.)
- Merck & Co., Inc. (U.S.)
- Vetoquinol (France)
- Virbac (France)
- Norbrook (U.K.)
- FARMABASE (Spain)
- Ourofino Saúde Animal (Brazil)
- Phibro Animal Health Corporation (U.S.)
- PetIQ, LLC (U.S.)
- Chanelle Pharma (Ireland)
- Inmed Animal Health (U.S.)
- Viyash Scientific (India)
- Kyoritsu Seiyaku Corporation (Japan)
- KRKA, d. d., Novo mesto (Slovenia)
- Huvepharma (Bulgaria)
- Bioveta, a.s. (Czech Republic)
- Pecus Healthcare Pvt. Ltd. (India)
- PATCO Healthcare Pvt. Ltd. (India)
- Agrovet Market S.A. (Peru)
- Prodivet Pharmaceuticals S.A. (Belgium)
Latest Developments in North America Animal Parasiticides Market
- In September 2025, Zoetis Inc. announced that Dectomax-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days. This conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn calves and bulls.
- In February 2026, Boehringer Ingelheim, a global leader in animal health, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the use of IVOMEC (ivermectin) 1% Injection for the prevention of infestations caused by New World screwworm (NWS) in cattle. Under the EUA, IVOMEC (ivermectin) 1% Injection is authorized for the prevention of infestations caused by NWS (Cochliomyia hominivorax) larvae (myiasis) when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound in cattle, except for female dairy cattle producing milk for human consumption and calves that will be processed for veal.
- In June 2026, Ceva Animal Health announces the acquisition of Aquilón CyL S.L., a Spanish biotechnology company specialised in research, diagnostics, and the development of innovative biological solutions for swine diseases. This acquisition enhances Ceva’s swine intestinal health portfolio. It includes the first and only European commercial vaccine targeting Brachyspira hyodysenteriae, the bacterium responsible for swine dysentery, a major enteric disease causing severe economic losses globally.
- In May 2026, Ceva Animal Health (Ceva) and Mitsui & Co., Ltd. (Mitsui) announced the creation of Ceva Bussan Animal Health, a new joint venture that brings together Bussan Animal Health (BAH) and Ceva Japan. As part of the transaction, Mitsui has transferred 60% of its shareholding in BAH to Ceva. Ceva Bussan Animal Health will be operated by Ceva as a controlling shareholder and benefit from Mitsui’s ongoing support as a leading global trading and investment company headquartered in Japan.
- In February 2026, Ceva Animal Health is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate growth and drive operational excellence. As part of this strategic realignment, Ceva has relocated its Asia-Pacific regional headquarters to Shanghai, positioning the company to serve the dynamic markets in the region more effectively.
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ANIMAL PARASITICIDES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCT TYPE TIMELINE CURVE
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES ANALYSIS
4.1.1 THREAT OF NEW ENTRANTS
4.1.2 BARGAINING POWER OF SUPPLIERS
4.1.3 BARGAINING POWER OF BUYERS
4.1.4 THREAT OF SUBSTITUTE PRODUCTS
4.1.5 INDUSTRY RIVALRY
4.2 PESTEL ANALYSIS
4.2.1 INTRODUCTION
4.2.2 POLITICAL FACTORS
4.2.2.1 ANIMAL DISEASE CONTROL POLICIES
4.2.2.2 GOVERNMENT LIVESTOCK HEALTH PROGRAMS
4.2.2.3 ZOONOTIC DISEASE PREVENTION INITIATIVES
4.2.3 ECONOMIC FACTORS
4.2.4 RISING VETERINARY HEALTHCARE COSTS
4.2.4.1 LIVESTOCK PRODUCTIVITY INVESTMENTS
4.2.4.2 DEMAND FOR AFFORDABLE TREATMENTS
4.2.4.3 EXPANSION OF ANIMAL HEALTHCARE SPENDING
4.2.4.4 GENERIC PARASITICIDE ADOPTION
4.2.5 SOCIAL FACTORS
4.2.5.1 GROWING ANIMAL HEALTH AWARENESS
4.2.5.2 PREVENTIVE PARASITE MANAGEMENT PRACTICES
4.2.5.3 RISING PET OWNERSHIP TRENDS
4.2.5.4 ANIMAL WELFARE CONCERNS
4.2.5.5 DEMAND FOR BETTER VETERINARY CARE
4.2.6 TECHNOLOGICAL FACTORS
4.2.6.1 ADVANCED PARASITICIDE FORMULATIONS
4.2.6.2 NOVEL DRUG DELIVERY SYSTEMS
4.2.6.3 DIGITAL VETERINARY PLATFORMS
4.2.6.4 IMPROVED PARASITE DIAGNOSTICS
4.2.6.5 RESEARCH ON NEW MOLECULES
4.2.7 ENVIRONMENTAL FACTORS
4.2.7.1 PARASITICIDE RESIDUE CONCERNS
4.2.7.2 VETERINARY WASTE MANAGEMENT
4.2.7.3 SUSTAINABLE MANUFACTURING PRACTICES
4.2.7.4 ECO-FRIENDLY PACKAGING ADOPTION
4.2.7.5 RESISTANCE MANAGEMENT INITIATIVES
4.2.8 LEGAL FACTORS
4.2.8.1 VETERINARY DRUG APPROVAL STANDARDS
4.2.8.2 SAFETY AND EFFICACY REGULATIONS
4.2.8.3 RESIDUE LIMIT COMPLIANCE
4.2.8.4 ANIMAL MEDICINE GUIDELINES
4.2.8.5 NORTH AMERICA REGULATORY HARMONIZATION
4.2.9 CONCLUSION
4.3 PATENT ANALYSIS
4.3.1 PATENT NUMBER AND EXPIRY
4.3.2 COUNTRY-LEVEL APPROVAL
4.3.3 LIST OF PRODUCTS REACHING EXPIRY IN NEXT 3 YEARS
4.3.4 PRODUCTS PATENTED IN SPECIFIC COUNTRIES
4.3.5 CONCLUSION
4.4 INDUSTRY INSIGHTS
4.5 PIPELINE ANALYSIS
4.5.1 CLINICAL TRIALS AND PHASE ANALYSIS
4.5.2 PRODUCT PIPELINE FOR ANIMAL PARASITICIDES
4.5.3 TARGET ANIMAL SAFETY STUDIES (TASS)
4.5.4 TARGET ANIMAL EFFECTIVENESS STUDIES (TAES)
4.6 R & D ANALYSIS
4.7 EPIDEMIOLOGY
4.7.1 INTRODUCTION
4.7.2 INCIDENCE OF INFESTATION BY REGION
4.7.3 TREATMENT ADOPTION RATE
4.7.4 PARASITE-RELATED MORTALITY RATE
4.7.5 COMPLIANCE AND THERAPY SWITCH MODEL
4.7.6 TREATMENT SUCCESS RATES
4.7.7 CONCLUSION
4.8 MARKETED PRODUCT ANALYSIS
4.8.1 INTRODUCTION
4.8.2 PRODUCT
4.8.2.1 BRAND NAME
4.8.2.2 GENERIC NAME
4.8.3 THERAPEUTIC INDICATION
4.8.4 PHARMACOLOGICAL CLASSIFICATION
4.8.5 PRIMARY INDICATION
4.8.6 MARKET STATUS
4.8.7 MEDICATION TYPE
4.8.8 PRODUCT DOSAGE FORM
4.8.9 DOSAGE AVAILABILITY
4.8.10 PACKAGING TYPE
4.8.11 ROUTE OF ADMINISTRATION
4.8.12 DOSING FREQUENCY
4.8.13 PRODUCT INSIGHT
4.8.14 OVERVIEW OF PRODUCT DEVELOPMENT (REGULATORY MILESTONES, SAFETY, EFFICACY, MARKET EXCLUSIVITY DATA)
4.8.14.1 FORECAST MARKET OUTLOOK
4.8.14.2 CROSS COMPETITION
4.8.14.3 PRODUCT PORTFOLIO
4.8.14.4 URRENT DEVELOPMENT SCENARIO
4.8.15 CONCLUSION
4.9 MARKET ACCESS
4.9.1 INTRODUCTION
4.9.2 10-YEAR MARKET FORECAST
4.9.3 CLINICAL TRIAL RECENT UPDATES
4.9.4 ANNUAL NEW APPROVED PRODUCTS
4.9.5 MAJOR MANUFACTURERS AND PARTNERSHIPS
4.9.6 MAJOR PRODUCT UPTAKE
4.9.7 CURRENT TREATMENT PRACTICES
4.9.8 IMPACT OF UPCOMING THERAPY TRENDS
4.9.9 CONCLUSION
5 HEALTHCARE TARIFFS IMPACT ANALYSIS
5.1 OVERVIEW
5.2 TARIFF STRUCTURES
5.2.1 NORTH AMERICA VS. REGIONAL TARIFF STRUCTURES
5.2.1.1 NORTH AMERICA
5.2.1.2 EUROPE
5.2.1.3 ASIA-PACIFIC
5.2.1.4 LATIN AMERICA
5.2.1.5 MIDDLE EAST AND AFRICA
5.2.2 UNITED STATES: USDA AND FDA TARIFF POLICIES, CMS PRICING MODELS
5.2.3 EUROPEAN UNION: CROSS-BORDER TARIFF REGULATIONS, REIMBURSEMENT POLICIES
5.2.4 ASIA-PACIFIC: GOVERNMENT-IMPOSED TARIFFS ON IMPORTED VETERINARY PRODUCTS
5.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
5.3 PHARMACEUTICAL TARIFFS AND TRADE BARRIERS
5.3.1 IMPORT DUTIES ON VETERINARY DRUGS VS. GENERICS
5.3.2 IMPACT ON PRODUCT AFFORDABILITY AND ACCESS
5.3.3 KEY TRADE AGREEMENTS AFFECTING TARIFFS
5.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND ANIMAL OWNERS
5.4.1 COST BURDEN ON FARMS, HOSPITALS, AND VETERINARY CLINICS
5.4.2 EFFECT ON PET OWNER AFFORDABILITY AND INSURANCE COVERAGE
5.4.3 TARIFFS AND THEIR ROLE IN VETERINARY TOURISM
5.5 TRADE AGREEMENTS AND HEALTHCARE TARIFFS
5.5.1 WTO REGULATIONS ON HEALTHCARE TARIFFS
5.5.2 IMPACT OF TRADE WARS ON SUPPLY CHAIN
5.5.3 WTO ROLE OF FREE TRADE AGREEMENTS IN REDUCING TARIFFS
5.6 IMPACT OF TARIFFS ON COSTS AND ACCESSIBILITY
5.7 IMPORTANCE OF TARIFFS IN THE SECTOR
6 REGULATORY FRAMEWORK
6.1 INTRODUCTION
6.2 REGULATORY APPROVAL PROCESS
6.3 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
6.4 REGULATORY APPROVAL PATHWAYS
6.5 LICENSING AND REGISTRATION
6.6 POST-MARKETING SURVEILLANCE
6.7 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES
6.8 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH.
7.1.2 RISING PET HUMANIZATION AND GROWING EXPENDITURE ON COMPANION ANIMAL WELLNESS.
7.1.3 INCREASING IMPORTANCE OF LIVESTOCK DISEASE MANAGEMENT FOR FOOD SUPPLY CHAIN STABILITY
7.1.4 INCREASING VETERINARY RECOMMENDATIONS FOR PREVENTIVE PARASITE CONTROL PRACTICES
7.2 RESTRAINTS
7.2.1 DEVELOPMENT OF PARASITE RESISTANCE AGAINST COMMONLY USED ACTIVE INGREDIENTS.
7.2.2 STRICT REGULATORY APPROVAL REQUIREMENTS FOR VETERINARY PHARMACEUTICAL PRODUCTS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN DEMAND FOR NOVEL BIOLOGICAL AND LOW-CHEMICAL RESIDUE PARASITICIDE SOLUTIONS
7.3.2 EXPANSION OF ONLINE VETERINARY SERVICES AND DIGITAL ANIMAL HEALTHCARE PLATFORMS
7.3.3 DEVELOPMENT OF CUSTOMIZED PARASITE CONTROL SOLUTIONS BASED ON ANIMAL TYPE AND GEOGRAPHIC RISK
7.4 CHALLENGES
7.4.1 LIMITED VETERINARY INFRASTRUCTURE IN RURAL AND REMOTE FARMING COMMUNITIES
7.4.2 ENVIRONMENTAL IMPACT CONCERNS RELATED TO PARASITICIDE RESIDUES
8 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
8.2.1 ECTOPARASITICIDES
8.2.2 ENDOPARASITICIDES
8.2.3 ENDECTOCIDES
8.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
8.3.1 ECTOPARASITICIDES
8.3.2 ENDOPARASITICIDES
8.3.3 ENDECTOCIDES
8.4 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
8.4.1 ECTOPARASITICIDES
8.4.2 ENDOPARASITICIDES
8.4.3 ENDECTOCIDES
8.5 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
8.5.1 BY TYPE
8.5.2 BY DOSAGE FORM
8.5.3 BY ROUTE OF ADMINISTRATION
8.6 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.6.1 ORGANOPHOSPHATES
8.6.2 CARBAMATES
8.6.3 ORGANOCHLORINES
8.6.4 OTHERS
8.7 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.7.1 LINDANE
8.7.2 DIELDRIN
8.7.3 OTHERS
8.8 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.8.1 CARBARYL
8.8.2 METHOMYL
8.8.3 OTHERS
8.9 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.9.1 CHLORPYRIFOS
8.9.2 AZAMETHIPHOS
8.9.3 CHLORFENVINPHOS
8.9.4 OTHERS
8.1 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
8.10.1 SOLUTION
8.10.2 TABLETS
8.10.3 SPRAYS
8.10.4 OTHERS
8.11 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
8.11.1 TOPICAL
8.11.2 ORAL
8.11.3 OTHERS
8.12 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.12.1 NORTH AMERICA
8.12.2 EUROPE
8.12.3 ASIA-PACIFIC
8.12.4 SOUTH AMERICA
8.12.5 MIDDLE EAST & AFRICA
8.13 NORTH AMERICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
8.13.1 BY TYPE
8.13.2 BY DOSAGE FORM
8.13.3 BY ROUTE OF ADMINISTRATION
8.14 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.14.1 BENZIMIDAZOLES
8.14.2 IMIDAZOTHIAZOLES
8.14.3 OTHERS
8.15 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.15.1 ALBENDAZOLE
8.15.2 FENBENDAZOLE
8.15.3 FEBANTEL
8.15.4 OTHERS
8.16 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.16.1 LEVAMISOLE
8.16.2 TETRAMISOLE
8.16.3 OTHERS
8.17 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
8.17.1 SOLUTION
8.17.2 TABLETS
8.17.3 SPRAYS
8.17.4 OTHERS
8.18 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
8.18.1 ORAL
8.18.2 INJECTABLES
8.18.3 TOPICAL
8.18.4 OTHERS
8.19 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.19.1 NORTH AMERICA
8.19.2 EUROPE
8.19.3 ASIA-PACIFIC
8.19.4 SOUTH AMERICA
8.19.5 MIDDLE EAST & AFRICA
8.2 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.20.1 ABAMECTIN
8.20.2 DORAMECTIN
8.20.3 OTHERS
8.21 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.21.1 NORTH AMERICA
8.21.2 EUROPE
8.21.3 ASIA-PACIFIC
8.21.4 SOUTH AMERICA
8.21.5 MIDDLE EAST & AFRICA
9 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS
9.1 OVERVIEW
9.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
9.2.1 ORGANOCHLORINES
9.2.2 ORGANOPHOSPHATES
9.2.3 CARBAMATES
9.2.4 BENZIMIDAZOLES
9.2.5 IMIDAZOTHIAZOLES
9.2.6 OTHERS
9.3 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.3.1 NORTH AMERICA
9.3.2 EUROPE
9.3.3 ASIA-PACIFIC
9.3.4 SOUTH AMERICA
9.3.5 MIDDLE EAST & AFRICA
9.4 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.4.1 NORTH AMERICA
9.4.2 EUROPE
9.4.3 ASIA-PACIFIC
9.4.4 SOUTH AMERICA
9.4.5 MIDDLE EAST & AFRICA
9.5 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.5.1 NORTH AMERICA
9.5.2 EUROPE
9.5.3 ASIA-PACIFIC
9.5.4 SOUTH AMERICA
9.5.5 MIDDLE EAST & AFRICA
9.6 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.6.1 NORTH AMERICA
9.6.2 EUROPE
9.6.3 ASIA-PACIFIC
9.6.4 SOUTH AMERICA
9.6.5 MIDDLE EAST & AFRICA
9.7 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.7.1 NORTH AMERICA
9.7.2 EUROPE
9.7.3 ASIA-PACIFIC
9.7.4 SOUTH AMERICA
9.7.5 MIDDLE EAST & AFRICA
9.8 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.8.1 NORTH AMERICA
9.8.2 EUROPE
9.8.3 ASIA-PACIFIC
9.8.4 SOUTH AMERICA
9.8.5 MIDDLE EAST & AFRICA
10 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY MODE OF PURCHASE
10.1 OVERVIEW
10.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
10.2.1 PRESCRIPTION
10.2.2 OVER THE COUNTER (OTC)
10.3 NORTH AMERICA PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.3.1 NORTH AMERICA
10.3.2 EUROPE
10.3.3 ASIA-PACIFIC
10.3.4 SOUTH AMERICA
10.3.5 MIDDLE EAST & AFRICA
10.4 NORTH AMERICA OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.4.1 NORTH AMERICA
10.4.2 EUROPE
10.4.3 ASIA-PACIFIC
10.4.4 SOUTH AMERICA
10.4.5 MIDDLE EAST & AFRICA
11 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY DRUG TYPE
11.1 OVERVIEW
11.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
11.2.1 BRANDED
11.2.2 GENERIC
11.3 NORTH AMERICA BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.3.1 NORTH AMERICA
11.3.2 EUROPE
11.3.3 ASIA-PACIFIC
11.3.4 SOUTH AMERICA
11.3.5 MIDDLE EAST & AFRICA
11.4 NORTH AMERICA GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPE
11.4.3 ASIA-PACIFIC
11.4.4 SOUTH AMERICA
11.4.5 MIDDLE EAST & AFRICA
12 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
12.2.1 TOPICAL
12.2.2 ORAL
12.2.3 INJECTABLES
12.2.4 OTHERS
12.3 NORTH AMERICA TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.3.1 NORTH AMERICA
12.3.2 EUROPE
12.3.3 ASIA-PACIFIC
12.3.4 SOUTH AMERICA
12.3.5 MIDDLE EAST & AFRICA
12.4 NORTH AMERICA ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.4.1 NORTH AMERICA
12.4.2 EUROPE
12.4.3 ASIA-PACIFIC
12.4.4 SOUTH AMERICA
12.4.5 MIDDLE EAST & AFRICA
12.5 NORTH AMERICA INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.5.1 NORTH AMERICA
12.5.2 EUROPE
12.5.3 ASIA-PACIFIC
12.5.4 SOUTH AMERICA
12.5.5 MIDDLE EAST & AFRICA
12.6 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 NORTH AMERICA
12.6.2 EUROPE
12.6.3 ASIA-PACIFIC
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST & AFRICA
13 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY DOSAGE FORM
13.1 OVERVIEW
13.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
13.2.1 SOLUTION
13.2.2 TABLETS
13.2.3 SPRAYS
13.2.4 OTHERS
13.3 NORTH AMERICA SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.3.1 NORTH AMERICA
13.3.2 EUROPE
13.3.3 ASIA-PACIFIC
13.3.4 SOUTH AMERICA
13.3.5 MIDDLE EAST & AFRICA
13.4 NORTH AMERICA TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.4.1 NORTH AMERICA
13.4.2 EUROPE
13.4.3 ASIA-PACIFIC
13.4.4 SOUTH AMERICA
13.4.5 MIDDLE EAST & AFRICA
13.5 NORTH AMERICA SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 NORTH AMERICA
13.5.2 EUROPE
13.5.3 ASIA-PACIFIC
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST & AFRICA
13.6 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 NORTH AMERICA
13.6.2 EUROPE
13.6.3 ASIA-PACIFIC
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST & AFRICA
14 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY DISEASE TYPE
14.1 OVERVIEW
14.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE, 2018-2033 (USD THOUSAND)
14.2.1 FLEAS
14.2.2 TICKS
14.2.3 ROUND WORMS
14.2.4 HOOKWORMS
14.2.5 EAR MITES
14.2.6 OTHERS
14.3 NORTH AMERICA FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.3.1 NORTH AMERICA
14.3.2 EUROPE
14.3.3 ASIA-PACIFIC
14.3.4 SOUTH AMERICA
14.3.5 MIDDLE EAST & AFRICA
14.4 NORTH AMERICA TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.4.1 NORTH AMERICA
14.4.2 EUROPE
14.4.3 ASIA-PACIFIC
14.4.4 SOUTH AMERICA
14.4.5 MIDDLE EAST & AFRICA
14.5 NORTH AMERICA ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.5.1 NORTH AMERICA
14.5.2 EUROPE
14.5.3 ASIA-PACIFIC
14.5.4 SOUTH AMERICA
14.5.5 MIDDLE EAST & AFRICA
14.6 NORTH AMERICA HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.6.1 NORTH AMERICA
14.6.2 EUROPE
14.6.3 ASIA-PACIFIC
14.6.4 SOUTH AMERICA
14.6.5 MIDDLE EAST & AFRICA
14.7 NORTH AMERICA EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.7.1 NORTH AMERICA
14.7.2 EUROPE
14.7.3 ASIA-PACIFIC
14.7.4 SOUTH AMERICA
14.7.5 MIDDLE EAST & AFRICA
14.8 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.8.1 NORTH AMERICA
14.8.2 EUROPE
14.8.3 ASIA-PACIFIC
14.8.4 SOUTH AMERICA
14.8.5 MIDDLE EAST & AFRICA
15 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY ANIMAL TYPE
15.1 OVERVIEW
15.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
15.2.1 COMPANION ANIMAL
15.2.2 FARM ANIMALS
15.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
15.3.1 DOGS
15.3.2 CATS
15.3.3 HORSES
15.3.4 OTHER COMPANION ANIMALS
15.4 NORTH AMERICA COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.4.1 NORTH AMERICA
15.4.2 EUROPE
15.4.3 ASIA-PACIFIC
15.4.4 SOUTH AMERICA
15.4.5 MIDDLE EAST & AFRICA
15.5 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
15.5.1 CATTLE
15.5.2 SWINE
15.5.3 SHEEP AND GOATS
15.5.4 POULTRY
15.5.5 OTHER FARM ANIMALS
15.6 NORTH AMERICA FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.6.1 NORTH AMERICA
15.6.2 EUROPE
15.6.3 ASIA-PACIFIC
15.6.4 SOUTH AMERICA
15.6.5 MIDDLE EAST & AFRICA
16 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY END USER
16.1 OVERVIEW
16.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
16.2.1 VETERINARY CLINICS
16.2.2 ANIMAL FARMS
16.2.3 HOME CARE
16.2.4 VETERINARY HOSPITALS
16.2.5 PET SHOPS
16.2.6 OTHERS
16.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
16.3.1 VETERINARY CLINICS
16.3.2 ANIMAL FARMS
16.3.3 HOME CARE
16.3.4 VETERINARY HOSPITALS
16.3.5 PET SHOPS
16.3.6 OTHERS
16.4 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
16.4.1 VETERINARY CLINICS
16.4.2 ANIMAL FARMS
16.4.3 HOME CARE
16.4.4 VETERINARY HOSPITALS
16.4.5 PET SHOPS
16.4.6 OTHERS
16.5 NORTH AMERICA VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.5.1 NORTH AMERICA
16.5.2 EUROPE
16.5.3 ASIA-PACIFIC
16.5.4 SOUTH AMERICA
16.5.5 MIDDLE EAST & AFRICA
16.6 NORTH AMERICA ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.6.1 NORTH AMERICA
16.6.2 EUROPE
16.6.3 ASIA-PACIFIC
16.6.4 SOUTH AMERICA
16.6.5 MIDDLE EAST & AFRICA
16.7 NORTH AMERICA HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.7.1 NORTH AMERICA
16.7.2 EUROPE
16.7.3 ASIA-PACIFIC
16.7.4 SOUTH AMERICA
16.7.5 MIDDLE EAST & AFRICA
16.8 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
16.8.1 PRIVATE
16.8.2 PUBLIC
16.9 NORTH AMERICA VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.9.1 NORTH AMERICA
16.9.2 EUROPE
16.9.3 ASIA-PACIFIC
16.9.4 SOUTH AMERICA
16.9.5 MIDDLE EAST & AFRICA
16.1 NORTH AMERICA PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.10.1 NORTH AMERICA
16.10.2 EUROPE
16.10.3 ASIA-PACIFIC
16.10.4 SOUTH AMERICA
16.10.5 MIDDLE EAST & AFRICA
16.11 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.11.1 NORTH AMERICA
16.11.2 EUROPE
16.11.3 ASIA-PACIFIC
16.11.4 SOUTH AMERICA
16.11.5 MIDDLE EAST & AFRICA
17 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
17.2.1 RETAIL SALES
17.2.2 DIRECT TENDER
17.2.3 OTHER
17.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
17.3.1 RETAIL SALES
17.3.2 DIRECT TENDER
17.3.3 OTHER
17.4 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
17.4.1 RETAIL SALES
17.4.2 DIRECT TENDER
17.4.3 OTHER
17.5 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
17.5.1 OFFLINE SALES
17.5.2 ONLINE SALES
17.6 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.6.1 NORTH AMERICA
17.6.2 EUROPE
17.6.3 ASIA-PACIFIC
17.6.4 SOUTH AMERICA
17.6.5 MIDDLE EAST & AFRICA
17.7 NORTH AMERICA DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.7.1 NORTH AMERICA
17.7.2 EUROPE
17.7.3 ASIA-PACIFIC
17.7.4 SOUTH AMERICA
17.7.5 MIDDLE EAST & AFRICA
17.8 NORTH AMERICA OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.8.1 NORTH AMERICA
17.8.2 EUROPE
17.8.3 ASIA-PACIFIC
17.8.4 SOUTH AMERICA
17.8.5 MIDDLE EAST & AFRICA
18 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY REGION
18.1 NORTH AMERICA
18.1.1 U.S
18.1.2 CANADA
18.1.3 MEXICO
19 NORTH AMERICA ANIMAL PARASITICIDES MARKET COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: GLOBAL
20 SWOT ANALYSIS
21 COMPANY PROFILES
21.1 ZOETIS SERVICES LLC
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENT
21.2 MERCK & CO., INC
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMPANY SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENT
21.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
21.3.1 COMPANY SNAPSHOT
21.3.2 COMPANY SHARE ANALYSIS
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENT
21.4 ELANCO
21.4.1 COMPANY SNAPSHOT
21.4.2 REVENUE ANALYSIS
21.4.3 COMPANY SHARE ANALYSIS
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENT
21.5 CEVA
21.5.1 COMPANY SNAPSHOT
21.5.2 COMPANY SHARE ANALYSIS
21.5.3 PRODUCT PORTFOLIO
21.5.4 RECENT DEVELOPMENT
21.6 AGROVET MARKET ANIMAL HEALTH
21.6.1 COMPANY SNAPSHOT
21.6.2 PRODUCT PORTFOLIO
21.6.3 RECENT DEVELOPMENT
21.7 BIMEDA, INC.
21.7.1 COMPANY SNAPSHOT
21.7.2 PRODUCT PORTFOLIO
21.7.3 RECENT DEVELOPMENT
21.8 BIOGÉNESIS BAGÓ
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENT
21.9 BIOVETA, A.S
21.9.1 COMPANY SNAPSHOT
21.9.2 PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENT
21.1 CHANELLE PHARMA
21.10.1 COMPANY SNAPSHOT
21.10.2 PRODUCT PORTFOLIO
21.10.3 RECENT DEVELOPMENT/NEWS
21.11 DECHRA PHARMACEUTICALS
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENT
21.12 FARMABASE
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENT
21.13 HUVEPHARMA
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENT
21.14 INMED ANIMAL HEALTH
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENT/NEWS
21.15 KRKA, D. D., NOVO MESTO
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENT
21.16 KYORITSU SEIYAKU CORPORATION
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENT
21.17 NORBROOK
21.17.1 COMPANY SNAPSHOT
21.17.2 PRODUCT PORTFOLIO
21.17.3 RECENT DEVELOPMENT
21.18 OUROFINO SAÚDE ANIMAL
21.18.1 COMPANY SNAPSHOT
21.18.2 REVENUE ANALYSIS
21.18.3 PRODUCT PORTFOLIO
21.18.4 RECENT DEVELOPMENT
21.19 ATCO HEALTHCARE PVT. LTD.
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENT
21.2 PECUS HEALTHCARE PVT LTD
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENT
21.21 PETIQ, LLC
21.21.1 COMPANY SNAPSHOT
21.21.2 PRODUCT PORTFOLIO
21.21.3 RECENT DEVELOPMENT
21.22 PHIBRO
21.22.1 COMPANY SNAPSHOT
21.22.2 PRODUCT PORTFOLIO
21.22.3 RECENT DEVELOPMENT/NEWS
21.23 PRODIVET PHARMACEUTICALS
21.23.1 COMPANY SNAPSHOT
21.23.2 PRODUCT PORTFOLIO
21.23.3 RECENT DEVELOPMENT
21.24 VETOQUINOL
21.24.1 COMPANY SNAPSHOT
21.24.2 REVENUE ANALYSIS
21.24.3 PRODUCT PORTFOLIO
21.24.4 RECENT DEVELOPMENT
21.25 VIRBAC.
21.25.1 COMPANY SNAPSHOT
21.25.2 REVENUE ANALYSIS
21.25.3 PRODUCT PORTFOLIO
21.25.4 RECENT DEVELOPMENT
21.26 VIYASH SCIENTIFIC LTD.
21.26.1 COMPANY SNAPSHOT
21.26.2 PRODUCT PORTFOLIO
21.26.3 RECENT DEVELOPMENT/NEWS
21.26.4 PRODUCT PORTFOLIO
21.26.5 RECENT DEVELOPMENT
22 QUESTIONNAIRE
23 RELATED REPORTS
List of Table
TABLE 1 PESTEL ANALYSIS OVERVIEW
TABLE 2 GROWTH OPPORTUNITY MAPPING
TABLE 3 CLINICAL TRIAL MARKET FOR NORTH AMERICA ANIMAL PARASITICIDES MARKET
TABLE 4 DISTRIBUTION OF PROJECTS BY PARASITE TYPE AND PHASE NORTH AMERICA ANIMAL
TABLE 5 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE NORTH AMERICA ANIMAL PARASITICIDES MARKET
TABLE 6 COMPARATIVE EVOLUTION OF R&D STRATEGIES
TABLE 7 ANIMAL PARASITICIDE PRODUCT DEVELOPMENT LIFECYCLE
TABLE 8 REGULATORY MILESTONES ACROSS THE PRODUCT DEVELOPMENT LIFECYCLE
TABLE 9 EMERGING THERAPEUTIC INNOVATION ASSESSMENT
TABLE 10 MAJOR COLLABORATION MODELS IN ANIMAL PARASITICIDE R&D
TABLE 11 TEN-YEAR MARKET FORECAST, 2023–2033 (USD MILLION)
TABLE 12 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 13 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 14 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 15 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 16 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 17 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 18 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 19 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 21 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 22 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 23 NORTH AMERICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 24 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 25 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 27 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 28 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 29 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 30 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 31 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 33 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 36 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 37 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 38 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 39 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 40 NORTH AMERICA PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 41 NORTH AMERICA OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 42 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 NORTH AMERICA BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 44 NORTH AMERICA GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 45 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 46 NORTH AMERICA TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 47 NORTH AMERICA ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 48 NORTH AMERICA INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 49 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 50 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 51 NORTH AMERICA SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 52 NORTH AMERICA TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 53 NORTH AMERICA SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 54 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 55 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 56 NORTH AMERICA FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 57 NORTH AMERICA TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 58 NORTH AMERICA ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 59 NORTH AMERICA HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 60 NORTH AMERICA EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 61 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 62 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 63 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 64 NORTH AMERICA COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 65 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 66 NORTH AMERICA FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 67 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 68 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 69 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 70 NORTH AMERICA VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 71 NORTH AMERICA ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 72 NORTH AMERICA HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 73 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 74 NORTH AMERICA VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 75 NORTH AMERICA PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 76 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 77 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 78 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 79 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 80 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 81 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 82 NORTH AMERICA DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 83 NORTH AMERICA OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 84 NORTH AMERICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 85 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 86 USD THOUSAND
TABLE 87 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 88 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 89 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 90 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 91 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 94 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 96 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 97 NORTH AMERICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 98 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 99 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 102 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 103 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 105 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 106 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 108 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 109 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 110 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 112 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 113 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 114 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 115 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 116 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 117 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 118 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 119 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 120 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 USD THOUSAND
TABLE 122 US ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 123 US ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 124 US ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 125 US ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 126 US ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 127 US ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 US CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 129 US ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 130 US ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 131 US ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 132 US ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 133 US ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 134 US BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 US IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 US ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 137 US ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 138 US ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 139 US ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 140 US ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 141 US ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 US ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 143 US ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 144 US ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 145 US ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 US ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 147 US ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 148 US ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 149 US ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 150 US ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 151 US ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 152 US ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 153 US ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 154 US ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 155 US RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 USD THOUSAND
TABLE 157 CANADA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 158 CANADA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 159 CANADA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 160 CANADA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 161 CANADA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 162 CANADA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 CANADA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 CANADA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 165 CANADA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 166 CANADA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 167 CANADA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 168 CANADA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 CANADA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 CANADA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 171 CANADA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 172 CANADA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 173 CANADA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 CANADA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 175 CANADA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 176 CANADA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 CANADA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 178 CANADA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 179 CANADA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 180 CANADA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 CANADA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 182 CANADA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 183 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 184 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 185 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 186 CANADA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 187 CANADA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 188 CANADA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 189 CANADA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 190 CANADA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 USD THOUSNAD
TABLE 192 MEXICO ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 193 MEXICO ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 194 MEXICO ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 195 MEXICO ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 196 MEXICO ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 MEXICO ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 MEXICO CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 199 MEXICO ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 MEXICO ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 201 MEXICO ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 202 MEXICO ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 203 MEXICO ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 204 MEXICO BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 MEXICO IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 MEXICO ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 207 MEXICO ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 208 MEXICO ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 209 MEXICO ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 210 MEXICO ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 211 MEXICO ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 MEXICO ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 213 MEXICO ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 214 MEXICO ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 215 MEXICO ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 MEXICO ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 217 MEXICO ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 218 MEXICO ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 219 MEXICO ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 220 MEXICO ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 221 MEXICO ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 222 MEXICO ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 223 MEXICO ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 224 MEXICO ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 225 MEXICO RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA ANIMAL PARASITICIDES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ANIMAL PARASITICIDES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ANIMAL PARASITICIDES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ANIMAL PARASITICIDES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ANIMAL PARASITICIDES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA ANIMAL PARASITICIDES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA ANIMAL PARASITICIDES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA ANIMAL PARASITICIDES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA ANIMAL PARASITICIDES MARKET: MULTIVARIVATE MODELING
FIGURE 10 NORTH AMERICA ANIMAL PARASITICIDES MARKET: PRODUCT TYPE TIMELINE CURVE
FIGURE 11 NORTH AMERICA ANIMAL PARASITICIDES MARKET: APPLICATION COVERAGE GRID
FIGURE 12 NORTH AMERICA ANIMAL PARASITICIDES MARKET: SEGMENTATION
FIGURE 13 THREE SEGMENTS COMPRISE THE NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT (2025)
FIGURE 14 NORTH AMERICA ANIMAL PARASITICIDES MARKET: EXECUTIVE SUMMARY
FIGURE 15 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH IS EXPECTED TO DRIVE THE NORTH AMERICA ANIMAL PARASITICIDES MARKET DURING THE FORECAST PERIOD OF 2026 TO 2033.
FIGURE 16 ECTOPARASITICIDES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ANIMAL PARASITICIDES MARKET IN 2026 & 2033
FIGURE 17 STRATEGIC DECISIONS
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS
FIGURE 19 PESTEL ANALYSIS
FIGURE 20 TOP ENTITIES BASED ON R&D GLANCE FOR NORTH AMERICA ANIMAL PARASITICIDES MARKET
FIGURE 21 R & D ANALYSIS
FIGURE 22 DROC ANALYSIS
FIGURE 23 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, 2025
FIGURE 24 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, 2026 TO 2033 (USD THOUSAND)
FIGURE 25 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, CAGR (2026- 2033)
FIGURE 26 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, LIFELINE CURVE
FIGURE 27 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, 2025
FIGURE 28 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, 2026 TO 2033 (USD THOUSAND)
FIGURE 29 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, CAGR (2026- 2033)
FIGURE 30 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY P DRUG CLASS, LIFELINE CURVE
FIGURE 31 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , 2025
FIGURE 32 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , 2026 TO 2033 (USD THOUSAND)
FIGURE 33 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , CAGR (2026- 2033)
FIGURE 34 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , LIFELINE CURVE
FIGURE 35 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, 2025
FIGURE 36 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, TO 2033 (USD THOUSAND)
FIGURE 37 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, CAGR (2026- 2033)
FIGURE 38 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 39 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, 2025
FIGURE 40 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 41 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2026- 2033)
FIGURE 42 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 43 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, 2025
FIGURE 44 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, 2026 TO 2033 (USD THOUSAND)
FIGURE 45 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, CAGR (2026- 2033)
FIGURE 46 NORTH AMERICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, LIFELINE CURVE
FIGURE 47 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, 2025
FIGURE 48 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, 2026 TO 2033 (USD THOUSAND)
FIGURE 49 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, CAGR (2026- 2033)
FIGURE 50 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 51 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, 2025
FIGURE 52 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, 2026 TO 2033 (USD THOUSAND)
FIGURE 53 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, CAGR (2026- 2033)
FIGURE 54 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 55 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY END USER, 2025
FIGURE 56 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 57 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 58 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY END USER, LIFELINE CURVE
FIGURE 59 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 60 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 61 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 62 NORTH AMERICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 63 NORTH AMERICA ANIMAL PARASITICIDES MARKET: SNAPSHOT (2025)
FIGURE 64 NORTH AMERICA ANIMAL PARASITICIDES MARKET: COMPANY SHARE 2025 (%)
FIGURE 65 NORTH AMERICA ANIMAL PARASITICIDES MARKET-, SNAPSHOT (2025)
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
